(Q26823954)

Brian R. Wong

series ordinal

2

1 reference

language of work or name

1 reference

August 2014

1 reference

1 reference

19

1 reference

PubMed

issue

8

1 reference

PubMed

page(s)

1212-6

1 reference

The dynamics of macrophage lineage populations in inflammatory and autoimmune diseases

PubMed

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

Proinflammatory cytokines, IL-1β and TNF-α, induce expression of interleukin-34 mRNA via JNK- and p44/42 MAPK-NF-κB pathway but not p38 pathway in osteoblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

The three human monocyte subsets: implications for health and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

Increased serum enzyme levels associated with kupffer cell reduction with no signs of hepatic or skeletal muscle injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

The mechanism of shared but distinct CSF-1R signaling by the non-homologous cytokines IL-34 and CSF-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

Macrophage-colony stimulating factor and interleukin-34 induce chemokines in human whole blood

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

Transcriptional profiling and pathway analysis of CSF-1 and IL-34 effects on human monocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

Colony stimulating factors and myeloid cell biology in health and disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

Structural basis for the dual recognition of helical cytokines IL-34 and CSF-1 by CSF-1R

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

Human IL-34 and CSF-1 establish structurally similar extracellular assemblies with their common hematopoietic receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

The CSF-1 receptor ligands IL-34 and CSF-1 exhibit distinct developmental brain expression patterns and regulate neural progenitor cell maintenance and maturation

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

CSF-1R inhibition alters macrophage polarization and blocks glioma progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

Spleen serves as a reservoir of osteoclast precursors through vitamin D-induced IL-34 expression in osteopetrotic op/op mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

Receptor-type protein-tyrosine phosphatase ζ is a functional receptor for interleukin-34

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

Elevated serum and synovial fluid levels of interleukin-34 in rheumatoid arthritis: possible association with disease progression via interleukin-17 production

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14(bright)CD16+ monocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

Discovery of a cytokine and its receptor by functional screening of the extracellular proteome

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

1 reference

7 January 2021

Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling.

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

Monoclonal antibodies against macrophage colony-stimulating factor diminish the number of circulating intermediate and nonclassical (CD14(++)CD16(+)/CD14(+)CD16(++)) monocytes in rheumatoid arthritis patient

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

CSF-1 receptor-mediated differentiation of a new type of monocytic cell with B cell-stimulating activity: its selective dependence on IL-34.

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

Pivotal Advance: Avian colony-stimulating factor 1 (CSF-1), interleukin-34 (IL-34), and CSF-1 receptor genes and gene products

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

Pleiotropic effects of extended blockade of CSF1R signaling in adult mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

The critical role of IL-34 in osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

Therapeutic effects of anti-CD115 monoclonal antibody in mouse cancer models through dual inhibition of tumor-associated macrophages and osteoclasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

Comparative transcriptional profiling of 3 murine models of SLE nephritis reveals both unique and shared regulatory networks

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

Circulating CSF-1 promotes monocyte and macrophage phenotypes that enhance lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021

Increased levels of interleukin 34 in serum and synovial fluid are associated with rheumatoid factor and anticyclic citrullinated peptide antibody titers in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUDIS.2014.05.016

7 January 2021